184 related articles for article (PubMed ID: 14613174)
1. Total synthesis of the squalene synthase inhibitor zaragozic acid C by a carbonyl ylide cycloaddition strategy.
Nakamura S; Hirata Y; Kurosaki T; Anada M; Kataoka O; Kitagaki S; Hashimoto S
Angew Chem Int Ed Engl; 2003 Nov; 42(43):5351-5. PubMed ID: 14613174
[No Abstract] [Full Text] [Related]
2. Total syntheses of zaragozic acids A and C by a carbonyl ylide cycloaddition strategy.
Hirata Y; Nakamura S; Watanabe N; Kataoka O; Kurosaki T; Anada M; Kitagaki S; Shiro M; Hashimoto S
Chemistry; 2006 Dec; 12(35):8898-925. PubMed ID: 17106907
[TBL] [Abstract][Full Text] [Related]
3. A symmetry-based formal synthesis of zaragozic acid A.
Freeman-Cook KD; Halcomb RL
J Org Chem; 2000 Sep; 65(19):6153-9. PubMed ID: 10987953
[TBL] [Abstract][Full Text] [Related]
4. Total synthesis of the squalene synthase inhibitor zaragozic acid C.
Nakamura S
Chem Pharm Bull (Tokyo); 2005 Jan; 53(1):1-10. PubMed ID: 15635219
[TBL] [Abstract][Full Text] [Related]
5. Enantioselective synthesis of the dioxabicyclo[3.2.1]octane core of the zaragozic acids via intramolecular Wacker-type cyclisation reactions.
Perlmutter P; Selajerern W; Vounatsos F
Org Biomol Chem; 2004 Aug; 2(15):2220-8. PubMed ID: 15280959
[TBL] [Abstract][Full Text] [Related]
6. The squalestatins: decarboxy and 4-deoxy analogues as potent squalene synthase inhibitors.
Chan C; Andreotti D; Cox B; Dymock BW; Hutson JL; Keeling SE; McCarthy AD; Procopiou PA; Ross BC; Sareen M; Scicinski JJ; Sharratt PJ; Snowden MA; Watson NS
J Med Chem; 1996 Jan; 39(1):207-16. PubMed ID: 8568810
[TBL] [Abstract][Full Text] [Related]
7. Zaragozic acids D and D2: potent inhibitors of squalene synthase and of Ras farnesyl-protein transferase.
Dufresne C; Wilson KE; Singh SB; Zink DL; Bergstrom JD; Rew D; Polishook JD; Meinz M; Huang L; Silverman KC
J Nat Prod; 1993 Nov; 56(11):1923-9. PubMed ID: 8289063
[TBL] [Abstract][Full Text] [Related]
8. Massive production of farnesol-derived dicarboxylic acids in mice treated with the squalene synthase inhibitor zaragozic acid A.
Vaidya S; Bostedor R; Kurtz MM; Bergstrom JD; Bansal VS
Arch Biochem Biophys; 1998 Jul; 355(1):84-92. PubMed ID: 9647670
[TBL] [Abstract][Full Text] [Related]
9. Cyclopentanedi- and tricarboxylic acids as squalene synthase inhibitors: syntheses and evaluation.
Shen W; Garvey DS; Cohen J; Stein H; Rosenberg SH
Bioorg Med Chem Lett; 1998 Apr; 8(8):891-6. PubMed ID: 9871507
[TBL] [Abstract][Full Text] [Related]
10. Self-consistent synthesis of the squalene synthase inhibitor zaragozic acid C via controlled oligomerization.
Nicewicz DA; Satterfield AD; Schmitt DC; Johnson JS
J Am Chem Soc; 2008 Dec; 130(51):17281-3. PubMed ID: 19053214
[TBL] [Abstract][Full Text] [Related]
11. Zaragozic acids: a family of fungal metabolites that are picomolar competitive inhibitors of squalene synthase.
Bergstrom JD; Kurtz MM; Rew DJ; Amend AM; Karkas JD; Bostedor RG; Bansal VS; Dufresne C; VanMiddlesworth FL; Hensens OD
Proc Natl Acad Sci U S A; 1993 Jan; 90(1):80-4. PubMed ID: 8419946
[TBL] [Abstract][Full Text] [Related]
12. Discovery, biosynthesis, and mechanism of action of the zaragozic acids: potent inhibitors of squalene synthase.
Bergstrom JD; Dufresne C; Bills GF; Nallin-Omstead M; Byrne K
Annu Rev Microbiol; 1995; 49():607-39. PubMed ID: 8561474
[TBL] [Abstract][Full Text] [Related]
13. Scope and diastereoselectivity of the "interrupted" Feist-Bénary reaction.
Calter MA; Zhu C
Org Lett; 2002 Jan; 4(2):205-8. PubMed ID: 11796051
[TBL] [Abstract][Full Text] [Related]
14. [Development of Synthetic Strategies for Densely Oxygenated Natural Products: Total Synthesis of Lactacystin and Zaragozic Acid C Using Photochemical C(sp
Nagatomo M
Yakugaku Zasshi; 2019; 139(5):651-661. PubMed ID: 31061332
[TBL] [Abstract][Full Text] [Related]
15. Synthetic and computational studies on the tricarboxylate core of 6,7-dideoxysqualestatin H5 involving a carbonyl ylide cycloaddition-rearrangement.
Hodgson DM; Villalonga-Barber C; Goodman JM; Pellegrinet SC
Org Biomol Chem; 2010 Sep; 8(17):3975-84. PubMed ID: 20601984
[TBL] [Abstract][Full Text] [Related]
16. The preparation of zaragozic acid A analogues by directed biosynthesis.
Chen TS; Petuch B; MacConnell J; White R; Dezeny G; Arison B; Bergstrom JD; Colwell L; Huang L; Monaghan RL
J Antibiot (Tokyo); 1994 Nov; 47(11):1290-4. PubMed ID: 8002393
[TBL] [Abstract][Full Text] [Related]
17. Selective protection and relative importance of the carboxylic acid groups of zaragozic acid A for squalene synthase inhibition.
Biftu T; Acton JJ; Berger GD; Bergstrom JD; Dufresne C; Kurtz MM; Marquis RW; Parsons WH; Rew DR; Wilson KE
J Med Chem; 1994 Feb; 37(3):421-4. PubMed ID: 8308869
[TBL] [Abstract][Full Text] [Related]
18. A general access to zaragozic acids: total synthesis and structure elucidation of zaragozic acid D and formal syntheses of zaragozic acids A and C.
Wang Y; Metz P
Chemistry; 2011 Mar; 17(12):3335-7. PubMed ID: 21328504
[No Abstract] [Full Text] [Related]
19. Inhibitory activity to protein prenylation and antifungal activity of zaragozic acid D3, a potent inhibitor of squalene synthase produced by the fungus, Mollisia sp. SANK 10294.
Tanimoto T; Ohya S; Tsujita Y
J Antibiot (Tokyo); 1998 Apr; 51(4):428-31. PubMed ID: 9630865
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of squalene synthase but not squalene cyclase prevents mevalonate-mediated suppression of 3-hydroxy-3-methylglutaryl coenzyme A reductase synthesis at a posttranscriptional level.
Peffley DM; Gayen AK
Arch Biochem Biophys; 1997 Jan; 337(2):251-60. PubMed ID: 9016820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
